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Abstract
Purpose To report on the first clinical experience with
perfusion angiography (PA) of the foot in patients with
chronic critical limb ischemia.
Materials and Methods PA is a post-processing software
algorithm and no extra digital subtraction angiography
(DSA) has to be performed for this analysis. The data used
to test the feasibility of PA were obtained from a consec-
utive group of 89 patients with CLI who were treated with
standard below the knee angioplasty and 12 separate
patients who were not suitable for endovascular
revascularization.
Results Motion artifacts in the dataset of the DSA made
post-procedural analysis impossible in 10 % intervention.
In the majority of patients (59/68) PA showed an increase
in volume flow in the foot after successful angioplasty of
the crural vessels. However, in 9/68 patients no increase
was seen after successful angioplasty. With the use of a
local administered competitive a-adrenergic receptor
antagonist, it is also possible to test and quantify the cap-
illary resistance index which is a parameter for the
remaining functionality of the microcirculation in CLI
patients.
Conclusion PA might be used as a new endpoint for
lower limb revascularization and can also be used to test
the functionality the microcirculation to identify sub-types
of patients with CLI. Clinical evaluation and standardiza-
tion of PA is mandatory before introduction in daily
practice.
Keywords Experimental IR  Imaging  Clinical
practice  Arterial intervention  Diagnostic 
Arteriosclerosis  Diabetes  Ischemia
Introduction
Local perfusion problems in the foot, like a non-healing
ulcer, are often caused by macrovascular obstructions,
sometimes in combination with disease at the level of the
microcirculation of the foot. The latter is especially true for
arterial diabetic foot disease. Endovascular revasculariza-
tion of the macrovessels is the first-line treatment; how-
ever, there are no validated tests to predict the clinical
outcome after successful revascularization and often only
time will tell. Also a technically successful revasculariza-
tion on digital subtraction angiography (DSA) is not always
also a predictor for good outcome and vice versa. Any
increase in volume flow to the foot will only be clinically
beneficial when this also translates into a sufficient perfu-
sion of the capillaries and subsequent tissue oxygenation of
& Jim A. Reekers
j.a.reekers@amc.uva.nl




Ed T. van Bavel
e.vanbavel@amc.uva.n
1 Dept of Radiology, AMC, Meibergdreef 9, 1105 AZ
Amsterdam, The Netherlands
2 Dept of Vascular Surgery, AMC, Meibergdreef 9, 1105 AZ
Amsterdam, The Netherlands
3 Dept of Biomedical Engineering and Physics, AMC,
Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
4 Department of Radiology G1.206, Academic Medical Center,
University of Amsterdam, Meibergdreef 9, PO box 22660,
1100 DD Amsterdam, The Netherlands
123
Cardiovasc Intervent Radiol (2016) 39:183–189
DOI 10.1007/s00270-015-1253-6
the foot. Newly emerging techniques, especially those
based on magnetic resonance imaging, allow mapping of
areas of poor tissue oxygenation and perfusion of the whole
foot, beyond the skin [1]. These techniques are still under
development but moreover they are not instantly available
during a revascularization procedure for decision making.
Perfusion angiography (PA), which is a representation
of the time-density curve of contrast volume flow in the
foot, is a new imaging technique, using data from plain old
digital subtraction angiography, for assessment of foot
perfusion [2]. Studies to show the clinical validity of PA
are underway but will still take 2 years to be finished.
Because the PA software (Philips medical, Eindhoven,
The Netherlands) application is already commercially
available, we think it is important for the understanding




The data used to test the feasibility of PA were obtained
from a consecutive group of 89 patients, all with CLI
according to the European consensus document, who were
treated with standard below the knee angioplasty at our
institution during the last 18 months. These patients rep-
resent the normal CLI population with a broad scale of
underlying pathology like diabetes, atherosclerosis, M
Burger, and peripheral embolization. A separate group of
12 patient had, based on the extension of the disease and
the anatomy during DSA, no option for endovascular
treatment, and therefore the procedure was terminated after
diagnostic angiography.
Design Prospective observational data to test the feasi-
bility of PA.
All procedures performed in studies involving human
participants were in accordance with the ethical standards
of the institutional and/or national research committee and
with the 1964 Helsinki declaration and its later amend-
ments or comparable ethical standards.
Because no extra imaging was needed and the data were
not used in a clinical setting and no patients related
demographics were included in this first feasibility study,
informed consent was waved by our local medical ethical
committee.
Technique
The software for analyzing the perfusion is developed by
Philips medical (Best, The Netherlands) and is based on the
calculation of the change in density per pixel over time. For
post-procedural quantification of the perfusion with PA the
original DSA datasets obtained during angioplasty are
used. PA is a post-processing software algorithm and no
extra DSA has to be performed for this analysis. The cal-
culation was performed only after the procedure was fin-
ished and the PA data were not used for any decision
making.
In this group in which angioplasty was not performed,
vasodilation with tolazoline (Novartis, Basel Suisse) was
used as part of the diagnostic work-up procedure.
A standardized DSA protocol including lateral foot
projection was used in all patients pre- and post-crural
angioplasty. After selective ipsilateral femoral catheteri-
zation and, if necessary, endovascular optimization of the
flow in the above the trifurcation arteries, but before crural
angioplasty, a 5 Fr end-hole catheter is positioned at the
level of the mid-popliteal artery. Nine ml of Visipaque
320 mg I/ml (Iodixanol, GE healthcare, Cork Ireland) is
injected at a speed of 3 ml/s with 900 psi. The DSA is
made with the foot in lateral projection [2]. Because with
the current software any motion artifacts in the dataset of
the DSA will make post-procedural analysis impossible,
the foot is fixed in a dedicated footrest. DSA images are
obtained at a frame rate of 3/s. During 15–20 s. Change in
volume flow was measured as change in area under the
curve and change maximal peak density. To obtain a flow-
density curve on the workstation, a box was manually
placed over the region of the foot, not lower than the
middle cuneiform bone, where the arterial foot arch is
situated (Fig. 1A). With the available software, the start-
ing point of the time-density curves, pre- and post-revas-
cularization images, can be matched. The difference in
pre- and post-intervention perfusion is expressed in
change in area under the curve and change in maximal
peak density. The area under the curve is measured from
the starting point of the curve until the maximal peak
density in one of the two curves has been reached. The
change in perfusion is calculated in percentage in change
in the area under the curve (Fig. 1). The change in max-
imal peak density is calculated in percentage increase or
decrease. (Fig. 1).
Results
10 % (9/89) of the DSA datasets, pre- or post-angioplasty,
were not useful for PA analysis because of motion artifacts.
In 12 patients, crural angioplasty was not performed due to
the local anatomy or already major angiographic flow
improvement after an above-the-knee intervention. 68
patients were analyzed pre- and post-crural intervention. In
the majority of patients (59/68), PA showed an increase in
volume flow, both increase in area under the curve and
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maximal peak density, in the foot after successful angio-
plasty of the crural vessels. This improvement ranged from
\10 to 40 % for maximal peak density and from\10 to
[100 % for area under the curve. The average increase
after successful pta was 21 % for maximal peak density
and 48 % for area under the curve. In 9/68 patients, no
increase was seen after an angiographical successful
angioplasty. After revascularization, the increase in volume
flow was different for each individual patient and did not
show any direct relation to the original DSA appearance
pre- and post-intervention. Due to technical observational
design of this study, without patient informed consent, we
were not allowed to link PA changes to the clinical
outcome.
Pharmacological Stimulation
Vasodilation was used in the 12 patients without options
for a revascularization procedure below the knee. Tolazo-
line is a non-selective competitive a-adrenergic receptor
antagonist that gives a twofold to fivefold increase in A-V
shunting at capillaries level. Tolazoline, (4 mg) was diluted
in 10 ml saline and was injected through the catheter with
Fig. 1 CLI no diabetes and non-healing ulcer on the foot. A Occlu-
sion of the trifurcation. B Revascularization of the posterior tibial
artery, the only artery with direct outflow to the foot. C Outflow in the
foot. D Perfusion angiography pre- intervention (A) and post–
intervention (B) with ROI. e Strong improvement of flow after
revascularization. The area under the curve increased with 48 % and
the maximal density peak with 40 %
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the tip mid-popliteal. The delay after tolazoline to perform
a new DSA was 60 s. The response to tolazoline is an
instant first pass response after injection, which can
maintain up to 40 min. The response to tolazoline can be
quantified with the available software and was calculated
as the index, post divided by pre, of change in maximal
peak density. An index of 1 is equal to no change.
Results
PA after tolazoline showed a faster passage of contrast in
7/12 patient which resulted in an earlier and lower maximal
density peak (Fig. 2). The average index was 0.7. Five 5
patients however did not show any response to tolazoline
(Fig. 3). The average index was 1 (±0.1). In these patients,
the perfusion curves pre- and post-tolazoline overlapped.
All 5/12 patients who showed no response had diabetic foot
disease, while from the seven responders, 4/7 had
atherosclerosis and 3/7 diabetic foot disease. There is a
100 % correlation between non-responders and diabetic
foot disease.
Discussion
The microcirculation of the foot includes the terminal
arterioles and capillaries beyond the arteries that are
involved in transportation of the oxygen and blood nutri-
ents to the tissue.
Transport of oxygen to the tissue of the foot requires
blood flow through the capillaries and subsequent diffusion
of oxygen to the tissue. The capillary volume flow is
pressure dependent but capillary pressure cannot be mea-
sured directly and local arterial pressure in the pre-capillary
vessels (e.g., toe pressure) is not always proper proxy for
arterial insufficiency in the foot [3]. Subsequent transport
of oxygen from the capillaries to the tissue is by diffusion
and is not pressure dependent. Decrease in microcirculation
perfusion is therefore equal to decrease in available oxygen
for tissue oxygenation. Many patients with CLI, even
without calcified vessels, have a toe pressure above the
consensus document threshold for critical limb ischemia
[4–6]. Toe pressure is however a parameter of the macro-
circulation. These are patients where macrovascular blood
volume flow to the foot is sufficient, but the flow through
the microcirculation (perfusion in the foot)—and thus
oxygen transport—is insufficient. As there is a direct
relation between flow through the capillaries and the oxy-
genation of the tissue, a direct measurement of flow
through the capillaries, pre-and post-intervention, with PA
might be a good parameter for improved foot perfusion and
tissue oxygenation.
Until now all focus in CLI has been on the ulcer and the
ulcer healing. We think that the ulcer, and moreover the
non-healing ulcer, is a symptom of a general diseased
microcirculation of the foot. The first paradigm shift is that
not only the area of the ulcer is diseased but the whole foot
and that the general underlying microvascular pathology
will finally determine clinical outcome and not merely the
local perfusion improvement in the ulcer. Therefore, PA
looks at the overall perfusion of the foot and not merely at
ulcer region perfusion, because a non-healing ulcer is often
only a symptom of general microcirculation pathology. The
relation between inflow (macrocirculation) and capillary
flow, which is directly related to oxygenation of the tissue
Fig. 2 Diabetes and CLI and non-healing ulcer on the foot. Posterior
tibial artery occluded, stenosis (50 %) in anterior tibial artery.
A Initial angiography (ROI A) and angiography after tolazoline (ROI
B). B Faster flow with early maximal density peak after tolazoline.
The calculated capillary resistance index is 0.6. Follow-up: conser-
vative treatment with good healing of the ulcer no amputation
186 J. Reekers et al.: Functional Imaging of the Foot with Perfusion Angiography in Critical Limb…
123
of the foot, is very important for ulcer healing. An optimal
inflow with a poor capillary flow will lead to low tissue
oxygen and consequently poor ulcer healing. Visa versa, a
low inflow volume with a healthy microcirculation will
clinically often show no CLI but only intermittent claudi-
cation. This is also an explanation for the often contra-
dictory finding that in the first scenario vascularization on
angiography can sometimes be surprisingly good, while in
the other scenario the angiography can show poor vascu-
larization. This often poor relation between angiographic
appearance and clinical presentation is well known in daily
practice. Both the PA (capillary flow) respond to crural
revascularization as the PA respond to specific stimulation
of the microcirculation with tolazoline contains important
functional information about the microvascular function-
ality of the foot. This functionality of the microcirculation
could probably be a better predictor for outcome than, e.g.,
a technical successful revascularization.
The foot consists of[90 % microcirculation and\10 %
macrovessels. Therefore, the role of the macrocirculation in
the PA calculations is, although not zero, small. The flow
calculations are therefore only minimally influenced by the
macrovessels. However, in patients without intervention or
calculations pre-intervention this plays no role. This mini-
mal relation between macro- and microvascularisation is
also reflected in the clinical experience where it is known
that improving the inflow to the foot is not always a guar-
antee for a good clinical outcome [7–11]. The outcome of
CLI is very unpredictable, as is shown in the paper by
Lepantalo et al. [10]. This retrospective study evaluated 105
consecutive patients with 136 critically ischemic legs as
defined by the European Consensus Document on Chronic
Critical Leg Ischemia, who had no options for revascular-
ization. Fifty-four percent of these patients did not have an
amputation at the 12-month follow-up, and this result was
the same for diabetic and non-diabetic patients. On the other
hand, amputation despite successful revascularization is also
known. Even with a patent infrainguinal lower extremity
bypass for CLI, about 10 % of patients do not achieve
clinical improvement at 1-year follow-up [8–11].
Based on our initial experience with PA, we think that the
area under the curve and the maximal peak density are both
parameters of the total blood volume passing through the foot
(micro- and macrocirculation) over time. The length of the
curve (=time) is of less importance and the plateau phase is
probably more important. We hypothesize that in CLI a
significant increase in volume flow on PA, after a revascu-
larization procedure, might be a predictor for good outcome,
while minimal or no increase might be herald a bad outcome.
This creates the opportunity, as this is a instantly available
tool during endovascular treatment, for openingmore vessels
or outflow before ending a procedure to obtain optimal
inflow. The percentage in volume flow difference between
pre- and post-revascularization can therefore be used as a
new endpoint for (crural) revascularization in CLI. However,
the true cut-off point for a successful revascularization, based
on PA, still needs to be determined in a prospective clinical
study, which is currently underway.
Tolazoline is a non-selective competitive a-adrenergic
receptor antagonist that has the same effect as lumbal
sympathectomy, only short term. Like with sympathec-
tomy it widens the capillary resistance vessels and local
administration of tolazoline in the foot gives a twofold to
fivefold increase in A-V shunting at capillaries level, but
Fig. 3 Diabetes and CLI and non-healing ulcer on the foot. Three
tibial arteries are open with collateral outflow in the foot. A Initial
angiography (left) and angiography after tolazoline (right). B There is
no change in flow through the capillaries, both curves pre- and post-
tolazoline overlap. Calculated capillary resistance index is 1.
Conservative treatment. Follow-up: fast decline of the ulcer and
early amputation
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does not fully override or blocks the natural vasoconstric-
tive activity of the capillary sphincter [12, 13]. Tolazoline
has less effect on the afferent arterioles [12]. Tolazoline
works different from nitroglycerin or any other vasodilat-
ing drug, which mainly induces dilatation of the macro-
circulation and collaterals and can therefore not be used for
functional imaging. Pharmaco-stimulation of the micro-
circulation is a test to measure the remaining functionality.
When there is no response to tolazoline, there is probably
also little chance that any extra inflow of blood after
revascularization will be contributing to the tissue oxy-
genation. Because this is a functionality test, we presume
that the quantification of response to pharmacological
stimulation should better be calculated as an index; the
capillary resistance index (CRI). The equation is maximal
peak density after stimulation divided by the maximal peak
density pre. This index is automatically calculated by the
software on the workstation after manual placement of the
vertical lines (cursors) on the calculated perfusion curves
(Fig. 2). If there is a normal response with increase in
capillary AV-shunting after tolazoline, this results in a
faster passage time of the standardized contrast bolus and
subsequently a lower peak density The calculated CRI will
subsequently be\1 (Fig. 2). However, if the AV-shunting
does not increase, which is equal to absence of a good
functional response of the microcirculation, the pre- and
post-perfusion will be the same, and the CRI will be around
1. This was seen in five diabetes patients in our feasibility
study (Fig. 3). The CRI might therefore be a new param-
eter to test the degree of microcirculation disease and to
differentiate between diseases with or without microcir-
culation involvement, like in diabetic and atherosclerotic
foot disease. Unlike with measuring volume flow after
revascularization the change in volume flow during func-
tional imaging with pharmaco-stimulation is not equal to
absolute perfusion flow but only a parameter for the
functionality of the microcirculation.
CRI might also be a test to select patients who will have
a good outcome after revascularization and those who will
not. The latter also has huge implication regarding costs of
treatment.
Although PA looks very promising for functional
imaging of the foot in CLI, it will only be clinically
valuable with meticulous standardization and after proper
clinical evaluation. The standardization of the technique
and the reporting of outcome as discussed in this paper is
therefore absolutely mandatory for the success of PA.
In conclusion, our first experience to test the feasibility
of PA shows that the increase in volume flow in the foot
after revascularization can be instantly measured and
quantified with PA, and that this might be an important
new endpoint for any endovascular revascularization pro-
cedure. This endpoint could also hold important predictive
information about outcome, but this has to be investigated
in a prospective observational clinical trial with clinical
endpoints. Using a non-selective competitive a-adrenergic
receptor antagonist, it is possible to quantify the func-
tionality of the microcirculation in patients with CLI. The
CRI of the foot might allow for identification of different
sub-types of clinical and angiographic identical CLI
patients. PA might give important information about the
functionality of the microcirculation in CLI patients.
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